Clinical Trial Update: Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety of a single administration of the AAV2hAQP1 gene therapy to the parotid gland in patients with irradiation-induced xerostomi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation-induced Xerostomia
• Salivary Hypofunction
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• AAV2hAQP1 (AAV2hAQP1 gene therapy)

Snippet

Sponsor: MeiraGTx, LLC | Conditions: Squamous Cell Head and Neck Cancer, Radiation Induced Xerostomia | Phase 1 | Status: ACTIVE_NOT_RECRUITING